Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
285 |
|
Actual shortage: | 4 (1%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 16 (6%) | |
Resolved: | 265 (93%) | |
Discontinuation Reports |
51 |
|
To be discontinued: | 7 (14%) | |
Discontinued: | 44 (86%) | |
Reversed: | 0 (0%) | |
Late reports |
21 (6%) |
|
Overdue reports |
4 (36%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APIDRA | 100UNIT | SOLUTION | Resolved | 2022-08-26 | 2022-09-14 | 168019 |
APIDRA | 100UNIT | SOLUTION | Resolved | 2022-09-27 | 2022-10-12 | 170358 |
APIDRA | 100UNIT | SOLUTION | Resolved | 2022-10-18 | 2023-07-12 | 172103 |
APIDRA | 100UNIT | SOLUTION | Resolved | 2021-11-22 | 2021-11-24 | 149719 |
APIDRA | 100UNIT | SOLUTION | Resolved | 2022-01-21 | 2022-02-03 | 153367 |
APIDRA | 100UNIT | SOLUTION | Resolved | 2022-05-17 | 2022-06-02 | 160847 |
APIDRA | 100UNIT | SOLUTION | Resolved | 2022-06-29 | 2022-09-26 | 163664 |
APIDRA | 100UNIT | SOLUTION | Resolved | 2022-10-31 | 2023-07-12 | 173205 |
ARAVA | 10MG | TABLET | Resolved | 2022-08-02 | 2023-01-27 | 165914 |
ARAVA | 10MG | TABLET | Resolved | 2023-07-19 | 2023-11-28 | 199224 |
ARAVA | 20MG | TABLET | Resolved | 2023-02-15 | 2023-06-14 | 184712 |
ARAVA | 10MG | TABLET | Resolved | 2019-11-29 | 2020-04-25 | 100069 |
ARAVA | 20MG | TABLET | Resolved | 2019-11-29 | 2020-04-25 | 100066 |
ARAVA | 20MG | TABLET | Resolved | 2020-11-16 | 2020-12-02 | 128414 |
AUBAGIO | 14MG | TABLET | Resolved | 2022-04-25 | 2022-05-04 | 159348 |
AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2019-10-09 | 2020-01-24 | 95800 |
AVALIDE | 150MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-20 | 132678 |
AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-05-08 | 2019-05-10 | 83440 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |
FLAGYL | 500MG | CAPSULE | Discontinued | 2023-03-22 | 2023-03-22 | 187634 |
FLAGYL | 10% | CREAM | To be discontinued | 2024-03-28 | 2024-03-28 | 223877 |
IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98371 |
NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
NOVAHISTINE DH | 10MG 1.7MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98377 |
PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |
RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |